Omega-3 Fatty Acids के लिए Telogen Effluvium

Q: Does Omega-3 Fatty Acids help with Telogen Effluvium?

Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).

Q: How much Omega-3 Fatty Acids should I take for Telogen Effluvium?

Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Omega-3 Fatty Acids?

Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Omega-3 Fatty Acids and Telogen Effluvium?

We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

B संबंधित साक्ष्य कम से कम एक यादृच्छिक परीक्षण इसका समर्थन करता है, जिसके परिणाम अधिकतर सुसंगत हैं।

11 अध्ययनों पर आधारित, में कुल 317 प्रतिभागियों के साथ। 8/11 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Moderate evidence suggests that omega-3 fatty acids may help support hair recovery in telogen effluvium, though the research base is limited and they are usually studied alongside other nutrients.

8 out of 11 studies show positive effects, but total sample size is small (317 participants)
Often studied as part of multi-nutrient supplement formulations
No large-scale RCTs specifically for omega-3 and telogen effluvium
May support recovery through anti-inflammatory and nutritional mechanisms

Key Study Findings

review

Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.

Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 बनाम: Placebo प्रभाव: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None

narrative review

Herbal Remedies for Hair Loss: A Review of Efficacy and Safety.

Dose: varies by remedy and study बनाम: Placebo प्रभाव: None None

scoping_review n=16

A Scoping Review of Exosome Delivery Applications in Hair Loss.

Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) बनाम: Placebo प्रभाव: None None

review

The Use of Light-Based Therapies in the Treatment of Alopecia.

Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri बनाम: Placebo प्रभाव: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None

Cohort n=200 Open-label

Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life …

Dose: high dose elemental iron (dose unspecified) बनाम: Placebo प्रभाव: Patients with baseline ferritin ≥50 ng/ml mostly 'very satisfied'; patients with ferritin <50 ng/ml None

clinical trial (open-label)

Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with …

Dose: None बनाम: Placebo प्रभाव: None None

Key Statistics

अध्ययन

317

प्रतिभागी

↑

Positive

ग्रेड

Referenced Papers

Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. Review

American journal of … 2026 1 उद्धरण

A Scoping Review of Exosome Delivery Applications in Hair Loss. Review

Cureus 2025 7 उद्धरण

Herbal Remedies for Hair Loss: A Review of Efficacy and Safety. Review

Skin appendage disorders 2025 7 उद्धरण

The Use of Light-Based Therapies in the Treatment of Alopecia. Review

Journal of cosmetic … 2025

Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. Other

Indian journal of … 2024 4 उद्धरण

Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic … Other

Journal of cosmetic … 2023 6 उद्धरण

Role of nutritional supplements in selected dermatological disorders: A review. Review

Journal of cosmetic … 2022 30 उद्धरण

NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Observational

Journal of cosmetic … 2019 25 उद्धरण

Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. Case Report

Acta dermatovenerologica Croatica … 2016 6 उद्धरण

[Effectiveness of the treatment plan for androgenetic alopecia]. Other

Georgian medical news 2007

[Diffuse hair loss in women]. Other

Therapeutische Umschau. Revue … 2002 4 उद्धरण

Management of hair loss in women. Review

Dermatologic clinics 1993 38 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:: 250-500 mg EPA+DHA/day
hairloss:: 1,000-2,000 mg/day

अधिकतम सीमा: 3,000 mg/day EPA+DHA

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5	--	Positive	--
varies by remedy and study	--	Positive	--
variable; exosomes predominantly from mesenchymal stem cells (MSCs)	--	Positive	16
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri	--	Positive	--
high dose elemental iron (dose unspecified)	--	Positive	200
None	--	Positive	--
None	--	Neutral	100
psychiatric and dermatological management	--	Neutral	1

सेवन का सर्वोत्तम समय: With meals containing fat for optimal absorption; split doses if over 1,000 mg

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Fishy aftertaste or burping
⚠ Mild gastrointestinal upset (nausea, diarrhea)
⚠ Possible increased bleeding time at high doses
⚠ Unpleasant body odor at very high doses

ज्ञात अंतःक्रियाएँ

● Anticoagulants (warfarin) and antiplatelet drugs (may increase bleeding risk)
● Blood pressure medications (additive hypotensive effect)
● Orlistat (reduces omega-3 absorption)

सहनीय अधिकतम सेवन: 3,000 mg/day EPA+DHA

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids help with Telogen Effluvium?

Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).

How much Omega-3 Fatty Acids should I take for Telogen Effluvium?

Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Omega-3 Fatty Acids?

Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Omega-3 Fatty Acids and Telogen Effluvium?

We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री Telogen Effluvium

Minoxidil A Black Seed Oil A Viviscal A Iron B Keratin B Folate B

Omega-3 Fatty Acids अन्य स्वास्थ्य स्थितियों के लिए

Androgenetic Alopecia A

संक्षिप्त निष्कर्ष

Evidence Strength72%

High confidence

अध्ययन विश्लेषण

RCT (0)Meta (0)Other (11)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Telogen Effluvium

अधिक जानें

References

[1] Michael M Ong et al.. Am J Clin Dermatol. 2026. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. doi:10.1007/s40257-025-00990-4 PubMed
[2] Sarah Schaffer et al.. Cureus. 2025. A Scoping Review of Exosome Delivery Applications in Hair Loss. doi:10.7759/cureus.81152 PubMed
[3] Azhar Ahmed et al.. Skin Appendage Disord. 2025. Herbal Remedies for Hair Loss: A Review of Efficacy and Safety. doi:10.1159/000542876 PubMed
[4] Robert J Vanaria et al.. J Cosmet Dermatol. 2025. The Use of Light-Based Therapies in the Treatment of Alopecia. doi:10.1111/jocd.70434 PubMed
[5] Boutros Soutou et al.. Indian J Dermatol. 2024. Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. doi:10.4103/ijd.ijd_744_22 PubMed
[6] S Cedirian et al.. J Cosmet Dermatol. 2023. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic … doi:10.1111/jocd.15873 PubMed
[7] Kabir Sardana et al.. J Cosmet Dermatol. 2022. Role of nutritional supplements in selected dermatological disorders: A review. doi:10.1111/jocd.14436 PubMed
[8] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
[9] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
[10] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
[11] R M Trüeb. Ther Umsch. 2002. [Diffuse hair loss in women]. doi:10.1024/0040-5930.59.5.217 PubMed
[12] D H Rushton. Dermatol Clin. 1993. Management of hair loss in women. PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।